期刊名称：FOOD AND CHEMICAL TOXICOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Food and Chemical Toxicology publishes original research reports and occasional interpretative reviews on the toxic effects, in animals or humans, of natural or synthetic chemicals occurring in the human environment. In addition to studies relating to food, water and other consumer products, papers on industrial and agricultural chemicals and pharmaceuticals are encouraged. Furthermore new areas such as safety evaluation of novel foods and biotechnologically derived products and inter-relationships between nutrition and toxicology are welcomed. The studies may address the physiological, biochemical or pathological changes induced by specific substances, techniques for assessing potential toxicity, including molecular biology or the mechanisms underlying toxic phenomena. All aspects of in vivo toxicology are covered, including systemic effects on specific organ systems, immune functions, carcinogenesis and teratogenesis. Papers reporting the toxicological examination of specific chemicals or consumer products are published irrespective of the positive or negative nature of the results, provided the tests and reporting meet current standards of adequacy. The Journal's editorial policy reflects the need for high-quality science in support of health and safety decisions. FCT is willing to consider papers of a more regulatory nature, provided they are part of a more general scientific analysis. On acceptance these papers will be published in a Regulatory Toxicology section. We recommend that before submitting a regulatory paper one of the editors of the journal is contacted.
Instructions to Authors
Food and Chemical Toxicology publishes original research reports and occasional interpretative reviews on the toxic effects, in animals or humans, of natural or synthetic chemicals occurring in the human environment. In addition to studies relating to food, water and other consumer products, papers on industrial and agricultural chemicals and pharmaceuticals are encouraged. Furthermore new areas such as safety evaluation of novel foods and biotechnologically derived products and inter-relationships between nutrition and toxicology are welcomed. The studies may address the physiological, biochemical or pathological changes induced by specific substances, techniques for assessing potential toxicity, including molecular biology or the mechanisms underlying toxic phenomena. All aspects of in vivo toxicology are covered, including systemic effects on specific organ systems, immune functions, carcinogenesis and teratogenesis. Papers reporting the toxicological examination of specific chemicals or consumer products are published irrespective of the positive or negative nature of the results, provided the tests and reporting meet current standards of adequacy. The Journal's editorial policy reflects the need for high-quality science in support of health and safety decisions. FCT is willing to consider papers of a more regulatory nature, provided they are part of a more general scientific analysis. On acceptance these papers will be published in a Regulatory Toxicology section. We recommend that before submitting a regulatory paper one of the editors of the journal is contacted.
Types of paper
The Journal's main purpose is the publication of papers reporting and interpreting original unpublished toxicological research, particularly studies promoting an understanding of the mechanisms underlying toxic effects or improvements in methods for predicting adverse effects. Papers reporting the toxicological examination of specific foods, chemicals or consumer products will be published, irrespective of the positive or negative nature of the results, provided the tests and reporting meet current standards of acceptability. In addition, Brief Communications will also be considered, as will concise interpretative Reviews of toxicological topics of contemporary significance. Letters to the Editor will be limited to comments on contributions already published n the journal; if a letter is accepted, a response (for simultaneous publication) will be invited from the authors of the original contribution.
Page charges
This journal has no page charges.
Ethics in Publishing
For information on Ethics in Publishing and Ethical guidelines for journal publication see http://www.elsevier.com/publishingethics and http://www.elsevier.com/ethicalguidelines.
Confict of interest statements for authors
All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. See also http://www.elsevier.com/conflictsofinterest.
Food and Chemical Toxicology requires full disclosure of all potential conflicts of interest. Please download the disclosure from the Food and Chemical Toxicology web site, http://ees.elsevier.com/fct at the 'Attach Files' stage of manuscript submission or download the form directly here. The corresponding author is responsible for downloading and sharing a copy of this form for each and every co-author listed on the manuscript. Each and every co-author must complete and sign their individual form and return to the corresponding author. The corresponding author is responsible for uploading their form and those of their co-authors (as one document) at the submission process. Investigators should disclose potential conflicts to participants in clinical trials and other studies and should state in the manuscript whether they have done so. Food and Chemical Toxicology may decide not to publish on the basis of a declared conflict, such as the financial interest of an author in a company (or its competitors) that makes a product discussed in the paper.
Submission declaration
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder.
Each manuscript must also be accompanied by a cover letter outlining the basic findings of the paper and their significance. Furthermore, it is understood that with submission of this article the authors have complied with the institutional policies governing the humane and ethical treatment of the experimental subjects, and that they are willing to share the original data and materials if so requested.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright see http://www.elsevier.com/copyright). Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations (please consult http://www.elsevier.com/permissions). If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult http://www.elsevier.com/permissions.
Retained author rights
As an author you (or your employer or institution) retain certain rights; for details you are referred to: http://www.elsevier.com/authorsrights.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. If the funding source(s) had no such involvement then this should be stated. Please see http://www.elsevier.com/funding.
Funding body agreements and policies
Elsevier has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please visit http://www.elsevier.com/fundingbodies.
Sponsored articles
This journal offers you the choice of making your article freely available to all on Elsevier's electronic publishing platforms. The charge for article sponsorship is $3,000, which is necessary to offset publishing costs. To prevent any conflict of interest, you can only make this choice after receiving notification that your article has been accepted for publication. Full details of the sponsored Open Access options available to you and your funding body can be found here: http://elsevier.com/locate/sponsoredarticles. Whatever access option you choose, you retain many rights as an author, including the right to post a revised personal version of your article on your own website. More information can be found here: http://elsevier.com/authorsrights.
Language and language services
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who require information about language editing and copyediting services pre- and post-submission please visit http://www.elsevier.com/languageediting or our customer support site at http://epsupport.elsevier.com for more information.
Submission
Submission to this journal proceeds totally online and you will be guided stepwise through the creation and uploading of your files. The system automatically converts source files to a single PDF file of the article, which is used in the peer-review process. Please note that even though manuscript source files are converted to PDF files at submission for the review process, these source files are needed for further processing after acceptance. All correspondence, including notification of the Editor's decision and requests for revision, takes place by e-mail removing the need for a paper trail.
Referees
The Editors welcome submissions by the authors of the names and addresses of up to five individuals who could expertly review the paper and who are not from the same institutions as the authors. The Editors reserve the right to use these or other reviewers.
Use of wordprocessing software
It is important that the file be saved in the native format of the wordprocessor used. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the wordprocessor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. Do not embed "graphically designed" equations or tables, but prepare these using the wordprocessor's facility. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier: http://www.elsevier.com/guidepublication). Do not import the figures into the text file but, instead, indicate their approximate locations directly in the electronic text and on the manuscript. See also the section on Electronic illustrations.
To avoid unnecessary errors you are strongly advised to use the "spell-check" and "grammar-check" functions of your wordprocessor.
Article structure
Subdivision - numbered sections
Divide your article into clearly defined and numbered sections. Subsections should be numbered 1.1 (then 1.1.1, 1.1.2, ...), 1.2, etc. (the abstract is not included in section numbering). Use this numbering also for internal cross-referencing: do not just refer to "the text". Any subsection may be given a brief heading. Each heading should appear on its own separate line.
Introduction
State the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.
Material and methods
Provide sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a reference: only relevant modifications should be described.
Results
Results should be clear and concise.
Discussion
This should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion of published literature.
Conclusions
The main conclusions of the study may be presented in a short Conclusions section, which may stand alone or form a subsection of a Discussion or Results and Discussion section.
Essential title page information
• Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.
• Author names and affiliations. Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name, and, if available, the e-mail address of each author.
• Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that telephone and fax numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address.
• Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a "Present address" (or "Permanent address") may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
Abstract
A concise and factual abstract is required. The abstract should state briefly the purpose of the research, the principal results and major conclusions. An abstract is often presented separately from the article, so it must be able to stand alone. For this reason, References should be avoided, but if essential, then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself.
Graphical abstract
A Graphical abstract is optional and should summarize the contents of the paper in a concise, pictorial form designed to capture the attention of a wide readership online. Authors must provide images that clearly represent the work described in the paper. Graphical abstracts should be submitted as a separate file in the online submission system. Maximum image size: 400 × 600 pixels (h × w, recommended size 200 × 500 pixels). Preferred file types: TIFF, EPS, PDF or MS Office files. See http://www.elsevier.com/graphicalabstracts for examples.
Research highlights
Research highlights are a short collection of bullet points that convey the core findings of the article. Research highlights are optional and should be submitted in a separate file in the online submission system. Please use 'Research highlights' in the file name and include 3 to 5 bullet points (maximum 85 characters per bullet point including spaces). See http://www.elsevier.com/researchhighlights for examples.
Keywords
Immediately after the abstract, provide a maximum of 6 keywords, using British spelling and avoiding general and plural terms and multiple concepts (avoid, for example, "and", "of"). Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible. These keywords will be used for indexing purposes.
Abbreviations
Abbreviations should be used sparingly; they should be defined when first used in the paper but also listed in alphabetical order under Abbreviations as a footnote to the title page (see above).
Acknowledgements
Collate acknowledgements in a separate section at the end of the article before the references and do not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those individuals who provided help during the research (e.g., providing language help, writing assistance or proof reading the article, etc.).
Nomenclature and units
All measurements should be expressed in metric, preferably SI, units. Test chemicals and enzymes must be clearly identified, IUPAC and CAS names being used, wherever possible with the aid of CAS Registry and EC numbers. Pesticides should be referred to be their ISO names and human and veterinary drugs by their INNs.
Gene accession numbers
In the electronic version of a published manuscript, gene accession numbers will be linked directly to the gene's description in NCBI's Nucleotide sequence database. The accession number should be formatted as follows:
Accession no. AJ315850
and in the text e.g. ". . . at the amino acid sequence level to the human IDN3 gene (Accession No. AJ315850)."
The production department will then link this reference when they find it in the text. Authors should DOUBLE-CHECK the number they use to make absolutely sure that it is correct before referring to it in their paper. Accession numbers in proofs should also always be checked for correctness. The number is an essential part of the link.
Footnotes
Footnotes should be used sparingly. Number them consecutively throughout the article, using superscript Arabic numbers. Many wordprocessors build footnotes into the text, and this feature may be used. Should this not be the case, indicate the position of footnotes in the text and present the footnotes themselves separately at the end of the article. Do not include footnotes in the Reference list.
Table footnotes
Indicate each footnote in a table with a superscript lowercase letter.
Artwork
Electronic artwork
General points
• Make sure you use uniform lettering and sizing of your original artwork.
• Save text in illustrations as "graphics" or enclose the font.
• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Produce images near to the desired size of the printed version.
• Submit each figure as a separate file.
A detailed guide on electronic artwork is available on our website:
http://www.elsevier.com/artworkinstructions
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats
Regardless of the application used, when your electronic artwork is finalised, please "save as" or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
EPS: Vector drawings. Embed the font or save the text as "graphics".
TIFF: color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.
DOC, XLS or PPT: If your electronic artwork is created in any of these Microsoft Office applications please supply "as is".
Please do not:
• Supply embedded graphics in your wordprocessor (spreadsheet, presentation) document;
• Supply files that are optimised for screen use (like GIF, BMP, PICT, WPG); the resolution is too low;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Color artwork
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure, at no additional charge, that these figures will appear in color on the Web (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in color in the printed version. For color reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article. Please indicate your preference for color in print or on the Web only. For further information on the preparation of electronic artwork, please see http://www.elsevier.com/artworkinstructions.
Please note: Because of technical complications which can arise by converting color figures to "gray scale" (for the printed version should you not opt for color in print) please submit in addition usable black and white versions of all the color illustrations.
Figure captions
Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Tables
Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables below the table body and indicate them with superscript lowercase letters. Avoid vertical rules. Be sparing in the use of tables and ensure that the data presented in tables do not duplicate results described elsewhere in the article.
References
Citation in text
Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Any references cited in the abstract must be given in full. Unpublished results and personal communications are not recommended in the reference list, but may be mentioned in the text. If these references are included in the reference list they should follow the standard reference style of the journal and should include a substitution of the publication date with either "Unpublished results" or "Personal communication" Citation of a reference as "in press" implies that the item has been accepted for publication.
Reference management software
This journal has standard templates available in key reference management packages EndNote ( http://www.endnote.com) and Reference Manager ( http://www.refman.com). Using plug-ins to wordprocessing packages, authors only need to select the appropriate journal template when preparing their article and the list of references and citations to these will be formatted according to the journal style which is described below.
Reference style
Text: All citations in the text should refer to:
1. Single author: the author's name (without initials, unless there is ambiguity) and the year of publication;
2. Two authors: both authors' names and the year of publication;
3. Three or more authors: first author's name followed by "et al." and the year of publication.
Citations may be made directly (or parenthetically). Groups of references should be listed first alphabetically, then chronologically.
Examples: "as demonstrated (Allan, 1996a, 1996b, 1999; Allan and Jones, 1995). Kramer et al. (2000) have recently shown ...."
List: References should be arranged first alphabetically and then further sorted chronologically if necessary. More than one reference from the same author(s) in the same year must be identified by the letters "a", "b", "c", etc., placed after the year of publication.
Examples:
Reference to a journal publication:
Van der Geer, J., Hanraads, J.A.J., Lupton, R.A., 2000. The art of writing a scientific article. J. Sci. Commun. 163, 51–59.
Reference to a book:
Strunk Jr., W., White, E.B., 1979. The Elements of Style, third ed. Macmillan, New York.
Reference to a chapter in an edited book:
Mettam, G.R., Adams, L.B., 1999. How to prepare an electronic version of your article, in: Jones, B.S., Smith , R.Z. (Eds.), Introduction to the Electronic Age. E-Publishing Inc., New York, pp. 281–304.
Journal abbreviations source
Journal names should be abbreviated according to
Index Medicus journal abbreviations: http://www.nlm.nih.gov/tsd/serials/lji.html;
List of serial title word abbreviations: http://www.issn.org/2-22661-LTWA-online.php;
CAS (Chemical Abstracts Service): http://www.cas.org/sent.html.
Video data
Elsevier accepts video material and animation sequences to support and enhance your scientific research. Authors who have video or animation files that they wish to submit with their article are strongly encouraged to include these within the body of the article. This can be done in the same way as a figure or table by referring to the video or animation content and noting in the body text where it should be placed. All submitted files should be properly labeled so that they directly relate to the video file's content. In order to ensure that your video or animation material is directly usable, please provide the files in one of our recommended file formats with a maximum size of 10 MB. Video and animation files supplied will be published online in the electronic version of your article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com. Please supply 'stills' with your files: you can choose any frame from the video or animation or make a separate image. These will be used instead of standard icons and will personalize the link to your video data. For more detailed instructions please visit our video instruction pages at http://www.elsevier.com/artworkinstructions. Note: since video and animation cannot be embedded in the print version of the journal, please provide text for both the electronic and the print version for the portions of the article that refer to this content.
Supplementary data
Elsevier accepts electronic supplementary material to support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish supporting applications, high-resolution images, background datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable, please provide the data in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption for each file. For more detailed instructions please visit our artwork instruction pages at http://www.elsevier.com/artworkinstructions.
Submission checklist
It is hoped that this list will be useful during the final checking of an article prior to sending it to the journal's Editor for review. Please consult this Guide for Authors for further details of any item.
Ensure that the following items are present:
One Author designated as corresponding Author:
• E-mail address
• Full postal address
• Telephone and fax numbers
All necessary files have been uploaded
• Keywords
• All figure captions
• All tables (including title, description, footnotes)
Further considerations
• Manuscript has been "spellchecked" and "grammar-checked"
• References are in the correct format for this journal
• All references mentioned in the Reference list are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Web)
• Color figures are clearly marked as being intended for color reproduction on the Web (free of charge) and in print or to be reproduced in color on the Web (free of charge) and in black-and-white in print
• If only color on the Web is required, black and white versions of the figures are also supplied for printing purposes
For any further information please visit our customer support site at http://epsupport.elsevier.com.
Use of the Digital Object Identifier
The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic information. The correct format for citing a DOI is shown as follows (example taken from a document in the journal Physics Letters B):
doi:10.1016/j.physletb.2003.10.071
When you use the DOI to create URL hyperlinks to documents on the web, they are guaranteed never to change.
Proofs
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the e-mail so that authors can download the files themselves. Elsevier now provides authors with PDF proofs which can be annotated; for this you will need to download Adobe Reader version 7 (or higher) available free from http://www.adobe.com/products/acrobat/readstep2.html. Instructions on how to annotate PDF files will accompany the proofs (also given online). The exact system requirements are given at the Adobe site: http://www.adobe.com/products/acrobat/acrrsystemreqs.html#70win.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return them to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. We will do everything possible to get your article published quickly and accurately. Therefore, it is important to ensure that all of your corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed with the publication of your article if no response is received.
Offprints
The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail. For an extra charge, paper offprints can be ordered via the offprint order form which is sent once the article is accepted for publication. The PDF file is a watermarked version of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use.
For inquiries relating to the submission of articles (including electronic submission where available) please visit this journal's homepage. You can track accepted articles at http://www.elsevier.com/trackarticle and set up e-mail alerts to inform you of when an article's status has changed. Also accessible from here is information on copyright, frequently asked questions and more. Contact details for questions arising after acceptance of an article, especially those relating to proofs, will be provided by the publisher.
Editorial Board
Editors
Joseph F. Borzelleca
President, Toxicology & Pharmacology, Inc., 8718 September Drive, Richmond, VA 23229-7319, USA, Email: josephfborzelleca@comcast.net
Alan R. Boobis
Experimental Medicine and Toxicology, Division of Investigative Science, Imperial College, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK, Email: a.boobis@imperial.ac.uk
Review Editor
Susan Barlow
Harrington House, 8 Harrington Road, Brighton, East Sussex, BN1 6RE, UK, Email: suebarlow@mistral.co.uk
Associate Editor
David J. Brusick
Brusick Consultancy, 123 Moody Creek Road, Bumpass, VA 23024, USA, Email: brusick41@aol.com
Samuel M. Cohen
Department of Pathology and Microbiology, University of Nebraska Medical Center, 983135 Nebraska Medical Center, Omaha, NE 68198-3135, USA, Email: scohen@unmc.edu
Bryan Delaney
Toxicology, Pioneer Hi-Bred International, 2450 SE Oak Tree Court, Ankeny, IA 50021-7102, USA, Email: bryan.delaney@pioneer.com
John Christian Larsen
Fødevareinstituttet- National Food Institute, Danmarks Tekniske Universitet (DTU), 19 Mørkhøj Bygade, DK-2860 Søborg, Denmark, Email: jchla@food.dtu.dk
Michael W. Pariza
Dept. of Food Microbiology & Toxicology, University of Wisconsin at Madison, 176 Microbial Sciences Building, 1550 Linden Drive, Madison, WI 53706, USA, Email: mwpariza@wisc.edu
Ivonne M.C.M. Rietjens
Sectie Toxicologie, Agrotechnologie en voedingswetenschappen (AFSG), Wageningen University, Postbus 8000, Bodenummer 92, 6700 EA Wageningen, Netherlands, Email: Ivonne.Rietjens@wur.nl
Gary Williams
Dept. of Pathology, New York Medical College, Basic Science Building, Room 413, Valhalla, NY 10595, USA, Email: gary_williams@nymc.edu
Founding Editor
The late Leon Golberg
International Editorial Board
P. Baldrick
Harrogate, England, UK
J.K. Chipman
Birmingham, UK
T.F.X. Collins
Y.P. Dragan
Wilmington, DE, USA
L.O. Dragsted
Frederiksberg C, Denmark
L.R. Ferguson
Auckland, New Zealand
S.J.S. Flora
Gwalior, India
H.-R. Glatt
Nuthetal, Germany
W.H. Glinsmann
Owings, MD, USA
Y. Hashimoto
Chiyoda-Ku, Japan
A.W. Hayes
Boston, MA, USA
Y. Hua
Hangzhou, China
S. Kacew
Ottawa, ON, Canada
I. Kimber
Manchester, UK
S. Knasmüller
Wien, Austria
B.G. Lake
Surrey, England, UK
R.W. Lane
Englewood Cliffs, NJ, USA
M.I. Luster
Morgantown, WV, USA
P. Magee
Coleraine, Co. Londonderry, UK
H.I. Maibach
San Francisco, CA, USA
D.B. McGregor
Aberdour, UK
K.T. Morgan
Loughborough, England, UK
R.J. Nicolosi
Lowell, MA, USA
D.E. Ray
Nottingham, UK
K. Rozman
Kansas City, KS, USA
W.H.M. Saris
Maastricht, Netherlands
R.C. Shank
Irvine, CA, USA
M. Smith
Vlaardingen, Netherlands
Y.-J. Surh
Seoul, South Korea
R.G. Tardiff
Vienna, VA, USA
S.L. Taylor
Lincoln, NE, USA
J.A. Thomas
Indianapolis, IN, USA
E. Vavasour
Ottawa, Canada
H. Verhagen
Bilthoven, Netherlands
A. Visconti
Bari, Italy
X. Wang
Nanjing, China
S. Yannai
Haifa, Israel
| 
刊名字顺( Alphabetical List of Journals):
返回页首 